Screener
Xenon Pharmaceuticals XENE Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Xenon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338244
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities (note 5) | 811,159 | 349,723 |
| Other receivables | 1,629 | 1,371 |
| Prepaid expenses and other current assets | 13,553 | 10,392 |
| Total current assets | 945,868 | 560,649 |
| Marketable securities, long-term (note 5) | 314,411 | 37,152 |
| Operating lease right-of-use asset, net (note 6) | 5,385 | 6,626 |
| Property, plant and equipment, net | 7,774 | 8,721 |
| Deferred tax assets | 14,361 | 12,864 |
Item 1. Financial Statements
FAQ
- What is Xenon Pharmaceuticals's total current assets?
- Xenon Pharmaceuticals (XENE) reported total current assets of $945.87M in Q2 2026.
- How has Xenon Pharmaceuticals's total current assets changed year-over-year?
- Xenon Pharmaceuticals's total current assets increased by 89.1% year-over-year, from $500.25M to $945.87M.
- What is the long-term trend for Xenon Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's total current assets has grown at a 25.3% compound annual growth rate (CAGR), from $181.78M to $560.65M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Xenon Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude